,i #aae? ,,congress #b;d ,session ,h4 ,r4 #eaji ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,febru>y #bg1 #bjah,ms4 ,ku/] ( ,new ,hamp%ire 7= h]self1 ,mr4 ,j5k9s ( ,we/ ,virg9ia1 ,mr4 ,mc,kinley1 ,ms4 ,blunt ,ro*e/]1 ,mr4 ,poliqu91 & ,mr4 ,c\rtney7 introduc$ ! foll[+ bill2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,a ,,bill ,to am5d ! #ba/ ,c5tury ,cures ,act to ensure ! equitable di/ribution ( res\rces to address ! opioid epidemic1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,f$]al ,opioid ,response ,fairness ,act ( #bjah4 #b4 ,equitable di/ribution ( res\rces to address ! opioid epidemic 7a7 ,9 g5]al ,! second s5t5ce 9 p>agraph 7#a7 ( section #ajjc7;c7 ( ! #ba/ ,c5tury ,cures ,act 7,public ,law #aad-bee2 #db ,u4,s4,c4 #bij;ee-#c note7 is am5d$ by /rik+ ,/ates ) an incid5ce or preval5ce ( opioid use disord]s t is sub/antially high] relative to o!r ,/ates4 & ins]t+ ,/ates-- 7,a7 ) a preval5ce ( opioid use disord]s & associat$ adv]se heal? effects1 includ+ neonatal ab/95ce syndrome1 t is sub/antially high] relative to o!r ,/ates2 & 7,b7 ) a p] capita prescription opioid1 h]o91 or syn!tic opioid ov]dose mortality rate t is sub/antially high] relative to o!r ,/ates4 4 7b7 ,m9imum am\nt ( grants ,section #ajjc7;c7 ( ! #ba/ ,c5tury ,cures ,act 7,public ,law #aad-bee2 #db ,u4,s4,c4 #bij;ee-#c note7 is am5d$ by add+ at ! end ! foll[+ new p>agraph3 7#c7 ,m9imum am\nt ( grants ,subject to ! availability ( appropriations1 ! am\nt ( a grant aw>d$ "u ?is subsection %all n be less ?an #e1jjj1jjj4 4 7c7 ,te*nical am5dm5t ,! fir/ s5t5ce 9 p>agraph 7#a7 ( section #ajjc7;c7 ( ! #ba/ ,c5tury ,cures ,act 7,public ,law #aad-bee2 #db ,u4,s4,c4 #bij;ee-#c note7 is am5d$ by /rik+ 9 accordance ) subp>agraph 7,b7 & ins]t+ 9 accordance ) p>agraph 7#b74 7d7 ,effective date ,! am5dm5ts made by subsections 7a7 & 7b7 %all take effect on ,octob] #a1 #bjah4